Covpdb










A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9 All




1501 Ligand(s)
Ligand Name
Ligand ID
Structure
#Protein-Ligand Complex(es)
1001 MIV-701 COVPDB903 1
1002 MIV-710 COVPDB980 1
1003 MIV-711 COVPDB977 1
1004 ML175 COVPDB1097 1
1005 m-(N,N,N-trimethylammonio)trifluoroacetophe COVPDB1135 1
1006 MOL-127 COVPDB3 1
1007 MOL-168 COVPDB51 1
1008 monobactam L29 COVPDB1050 2
1009 monobactam L61 COVPDB1047 1
1010 monobactam L62 COVPDB1048 1
1011 monobromobimane COVPDB458 1
1012 MOR-LEU-HPQ COVPDB19 1
1013 morpholine-4-carboxylic acid [1-(2-benzylsulfanyl-1-formyl-ethylcarbamoyl)-2-phenyl-ethyl]-amide COVPDB608 1
1014 MORPHOLINE-4-CARBOXYLIC ACID [1S-(2-BENZYLOXY-1R-CYANO-ETHYLCARBAMOYL)-3-METHYL-BUTYL]AMIDE COVPDB571 1
1015 morpholine-4-sulphinic acid COVPDB1322 3
1016 Moxalactam COVPDB191 4
1017 MPC-1 COVPDB1245 1
1018 MRTX849 COVPDB1258 1
1019 MS05 COVPDB593 1
1020 MS4138 COVPDB734 1
1021 MS453 COVPDB351 1
1022 MTSET COVPDB769 2
1023 MXG COVPDB1115 1
1024 N1-[(1R)-1-(DIHYDROXYBORYL)ETHYL]-N2-[(TERT-BUTOXYCARBONYL)-D-GAMMA-GLUTAMYL]-N6-[(BENZYLOXY)CARBONYL-L-LYSINAMIDE COVPDB575 1
1025 N1-[(1S)-4-(carbamoylamino)-1-cyanobutyl]-N'1-[(1R)-1-(thiophen-3-yl)ethyl]cyclobutane-1,1-dicarboxamide COVPDB599 1
1026 N-{1-[(2,4-dichlorophenoxy)acetyl]piperidin-4-yl}ethenesulfonamide COVPDB111 1
1027 N-[1-(2,6-dimethoxy-benzyl)-piperidin-4-yl]-4-mercapto-butyramide COVPDB777 1
1028 N-[1-(3-bromo-5,6-dimethoxy-benzyl)-piperidin-4-yl]-4-mercapto-butyramide COVPDB779 1
1029 N-(1-{[(5,7-dichloro-2,2-dimethyl-1,3-benzodioxol-4-yl)oxy]acetyl}piperidin-4-yl)ethenesulfonamide COVPDB109 1
1030 N-{1-[6-(phenylamino)pyrazin-2-yl]-1H-benzimidazol-6-yl}prop-2-enamide COVPDB179 1
1031 N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETH YL]-L-ALANINAMIDE COVPDB651 1
1032 N-[1-methyl-2-oxo-3-(1-{[4-(5-oxo-3-phenyl-5,6-dihydro-1,6-naphthyridin-2-yl)phenyl]methyl}piperidin-4-yl)-2,3-dihydro-1H-1,3-benzodiazol-5-yl]prop-2-enamide COVPDB829 1
1033 N-{1-[N-(2,4-dichlorophenyl)glycyl]piperidin-4-yl}ethenesulfonamide COVPDB110 1
1034 N-{1-[N-(4,5-dichloro-2-hydroxyphenyl)glycyl]piperidin-4-yl}ethenesulfonamide COVPDB107 1
1035 N-{1-[N-(4-chloro-5-iodo-2-methoxyphenyl)glycyl]piperidin-4-yl}ethenesulfonamide COVPDB108 2
1036 N-{1-[N-(5,7-dichloro-2,1,3-benzothiadiazol-4-yl)glycyl]piperidin-4-yl}ethenesulfonamide COVPDB112 1
1037 N-(1-Pyrenyl)iodoacetamide COVPDB91 1
1038 N-[(1R)-1-borono-3-methylbutyl]-N~2~-(2-chloro-4-methoxybenzene-1-carbonyl)-L-leucinamide COVPDB1000 1
1039 N-((1R,2S)-2-allyl-4-oxocyclobutyl)-4-methylbenzenesulfonamide COVPDB41 1
1040 N-{(1R)-3-phenyl-1-[2-(phenylsulfonyl)ethenyl]propyl}-N~2~-(piperazin-1-ylcarbonyl)-L-leucinamide COVPDB11 1
1041 N-[(1S)-1-benzyl-3-diazen-1-iumylidene-2-oxopropyl]glycinamide COVPDB100 1
1042 N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide COVPDB1482 1
1043 N-[(1S)-2-{[(3S)-1-benzyl-3-cyanopyrrolidin-3-yl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide COVPDB1481 1
1044 N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide COVPDB1480 1
1045 N-[(1S,2R,3R,4R,5R,6R)-3,4-dihydroxy-5-(hydroxymethyl)-7-oxabicyclo[4.1.0]heptan-2-yl]-2,2,2-trifluoroacetamide COVPDB895 1
1046 N-[(1S)-3-amino-1-ethyl-2,3-dioxopropyl]-2-chloro-4-(pyridin-2-ylmethoxy)-3-(trifluoromethyl)benzamide COVPDB1171 1
1047 N-[2-(1-maleimidyl)ethyl]-7-(diethylamino)coumarin-3-carboxamide COVPDB1089 1
1048 N-[2-[1-(N-BENZYLOXYCARBONYLAMINO)-3-METHYLBUTYL]THIAZOL-4-YLCARBONYL]-N'-(BENZYLOXYCARBONYL-L-LEUCINYL)HYDRAZIDE COVPDB952 1
1049 N-[2-[2,5-bis(oxidanylidene)pyrrol-1-yl]ethyl]-2,3-bis(oxidanyl)benzamide COVPDB232 2
1050 N-[2-({2-[(5-methoxypyridin-3-yl)amino]-5-(trifluoromethyl)pyrimidin-4-yl}amino)phenyl]prop-2-enamide COVPDB327 1